Header Logo

Connection

Stephen Jensik to Tacrolimus

Back to Details
This is a "connection" page, showing publications Stephen Jensik has written about Tacrolimus.
Stephen Jensik
Connection Strength
0.038
Tacrolimus
  1. Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.